Redefining the Future of Longevity
We develop innovative biotechnology solutions to understand, slow, and potentially reverse the biological processes associated with ageing.
The Challenge
Ageing is the primary risk factor for many of the world's most significant health challenges, including cardiovascular disease, neurodegenerative disorders, cancer, and metabolic disease. As populations continue to age, there is an urgent need for innovative therapies that target the biological mechanisms of ageing itself.
Our Science
Our research focuses on understanding the cellular and molecular mechanisms of ageing to develop next-generation therapeutics that improve tissue function, resilience, and long-term health.
Why It Matters
Extending healthy lifespan has the potential to transform healthcare by reducing the burden of chronic disease and improving quality of life across ageing populations.
About Us
Reprint Biology is an Australian biotechnology company focused on developing innovative therapies that target the biological processes of ageing. Our multidisciplinary team combines expertise across molecular biology, regenerative medicine, biotechnology, and translational research to advance scientific discoveries into real-world healthcare solutions.
Through rigorous research and strategic collaboration, we aim to accelerate the development of therapies that improve healthspan and redefine how age-related diseases are treated.
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!